ReviewCurrent opinion in chemical biology2010
Nanoscale interfaces to biology.
Review in Current opinion in chemical biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Structural characterization of protein-material interfacial interactions using lysine reactivity profiling-mass spectrometry.Nature protocols · 2023Review
- Ce-based solid-phase catalysts for phosphate hydrolysis as new tools for next-generation nanoarchitectonics.Science and technology of advanced materials · 2023Article
- DNA-nanoparticle interactions: Formation of a DNA corona and its effects on a protein corona.Biointerphases · 2020Article
- Automation and low-cost proteomics for characterization of the protein corona: experimental methods for big data.Analytical and bioanalytical chemistry · 2020Article
- The role of human serum and solution chemistry in fibrinogen peptide-nanoparticle interactions.Nanoscale advances · 2020Article
- Protein Corona in Response to Flow: Effect on Protein Concentration and Structure.Biophysical journal · 2018Article
- Nanoparticle-Cell Interactions: Relevance for Public Health.The journal of physical chemistry. B · 2018Review
- Nanoparticle-induced oxidation of corona proteins initiates an oxidative stress response in cells.Nanoscale · 2017Article
- Effect of the Protein Corona on Antibody-Antigen Binding in Nanoparticle Sandwich Immunoassays.Bioconjugate chemistry · 2017Article
- Combining an optical resonance biosensor with enzyme activity kinetics to understand protein adsorption and denaturation.Biomaterials · 2015Article
- Ligand synthesis and passivation for silver and large gold nanoparticles for single-particle-based sensing and spectroscopy.Methods in molecular biology (Clifton, N.J.) · 2013Article
- Article
- The toxicity outcome of silica nanoparticles (Ludox®) is influenced by testing techniques and treatment modalities.Analytical and bioanalytical chemistry · 2012Article
- Formation of nano-bio-complex as nanomaterials dispersed in a biological solution for understanding nanobiological interactions.Scientific reports · 2012Article
- More effective nanomedicines through particle design.Small (Weinheim an der Bergstrasse, Germany) · 2011Review
- Anodized 20 nm diameter nanotubular titanium for improved bladder stent applications.International journal of nanomedicine · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Nanotechnology has held great promise for revolutionizing biology. The biological behavior of nanomaterials depends primarily on how they interface to biomolecules and their surroundings. Unfortunately, interface issues like non-specific adsorption are still the biggest obstacles to the success of nanobiotechnology and nanomedicine, and have held back widespread practical use of nanotechnology in biology. Not only does the biological interface of nanoparticles (NPs) need to be understood and controlled, but also NPs must be treated as biological entities rather than inorganic ones. Furthermore, one can adopt an engineering perspective of the NP-biological interface, realizing that it has unique, exploitable properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.